Jiang L - Search Results

1

Comparing Bayesian early stopping boundaries for phase II clinical trials.

Jiang L, Yan F, Thall PF, Huang X. Jiang L, et al. Pharm Stat. 2020 Nov;19(6):928-939. doi: 10.1002/pst.2046. Epub 2020 Jul 27. Pharm Stat. 2020. PMID: 32720462 Free PMC article.

2

Design and inference for 3-stage bioequivalence testing with serial sampling data.

Yan F, Zhu H, Liu J, Jiang L, Huang X. Yan F, et al. Among authors: jiang l. Pharm Stat. 2018 Sep;17(5):458-476. doi: 10.1002/pst.1865. Epub 2018 May 3. Pharm Stat. 2018. PMID: 29726096 Free PMC article.

3

Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.

Lu X, Jiang L, Zhang L, Zhu Y, Hu W, Wang J, Ruan X, Xu Z, Meng X, Gao J, Su X, Yan F. Lu X, et al. Among authors: jiang l. Neoplasia. 2019 Jun;21(6):591-601. doi: 10.1016/j.neo.2019.04.003. Epub 2019 May 2. Neoplasia. 2019. PMID: 31055200 Free PMC article.

4

A Pre-operative Nomogram for Prediction of Lymph Node Metastasis in Bladder Urothelial Carcinoma.

Lu X, Wang Y, Jiang L, Gao J, Zhu Y, Hu W, Wang J, Ruan X, Xu Z, Meng X, Zhang B, Yan F. Lu X, et al. Among authors: jiang l. Front Oncol. 2019 Jun 21;9:488. doi: 10.3389/fonc.2019.00488. eCollection 2019. Front Oncol. 2019. PMID: 31293963 Free PMC article.

5

Epigenetic age acceleration of cervical squamous cell carcinoma converged to human papillomavirus 16/18 expression, immunoactivation, and favourable prognosis.

Lu X, Zhou Y, Meng J, Jiang L, Gao J, Fan X, Chen Y, Cheng Y, Wang Y, Zhang B, Yan H, Yan F. Lu X, et al. Among authors: jiang l. Clin Epigenetics. 2020 Feb 10;12(1):23. doi: 10.1186/s13148-020-0822-y. Clin Epigenetics. 2020. PMID: 32041662 Free PMC article.

6

RNA processing genes characterize RNA splicing and further stratify colorectal cancer.

Lu X, Zhou Y, Meng J, Jiang L, Gao J, Cheng Y, Yan H, Wang Y, Zhang B, Li X, Yan F. Lu X, et al. Among authors: jiang l. Cell Prolif. 2020 Aug;53(8):e12861. doi: 10.1111/cpr.12861. Epub 2020 Jun 28. Cell Prolif. 2020. PMID: 32596958 Free PMC article.

7

Continuously available ratio of SpO₂/FiO₂ serves as a noninvasive prognostic marker for intensive care patients with COVID-19.

Lu X, Jiang L, Chen T, Wang Y, Zhang B, Hong Y, Wang J, Yan F. Lu X, et al. Among authors: jiang l. Respir Res. 2020 Jul 22;21(1):194. doi: 10.1186/s12931-020-01455-4. Respir Res. 2020. PMID: 32698822 Free PMC article.

8

Multiomics data reveals the influences of myasthenia gravis on thymoma and its precision treatment.

Ruan X, Lu X, Gao J, Jiang L, Zhu Y, Zhou Y, Meng J, Yan H, Yan F, Wang F. Ruan X, et al. Among authors: jiang l. J Cell Physiol. 2021 Feb;236(2):1214-1227. doi: 10.1002/jcp.29928. Epub 2020 Jul 23. J Cell Physiol. 2021. PMID: 32700803

9

MOVICS: an R package for multi-omics integration and visualization in cancer subtyping.

Lu X, Meng J, Zhou Y, Jiang L, Yan F. Lu X, et al. Among authors: jiang l. Bioinformatics. 2021 Apr 1;36(22-23):5539-5541. doi: 10.1093/bioinformatics/btaa1018. Bioinformatics. 2021. PMID: 33315104

10

A group sequential design and sample size estimation for an immunotherapy trial with a delayed treatment effect.

Li B, Su L, Gao J, Jiang L, Yan F. Li B, et al. Among authors: jiang l. Stat Methods Med Res. 2021 Mar;30(3):904-915. doi: 10.1177/0962280220980780. Epub 2020 Dec 23. Stat Methods Med Res. 2021. PMID: 33357047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,307 results

Search Page

Filters